These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 7934748)

  • 1. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.
    Cheitlin MD; Douglas PS; Parmley WW
    Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S254-60. PubMed ID: 7934748
    [No Abstract]   [Full Text] [Related]  

  • 2. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.
    Cheitlin MD; Douglas PS; Parmley WW
    J Am Coll Cardiol; 1994 Oct; 24(4):874-80. PubMed ID: 7930219
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force II: Acquired valvular heart disease.
    Cheitlin MD; Bonow RO; Parmley WW; Roberts WC; Swan HJ; Williams JF
    J Am Coll Cardiol; 1985 Dec; 6(6):1209-14. PubMed ID: 2856840
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical approach and management of acquired valvular heart disease.
    Fuster V; Brandenburg RO; Giuliani ER; McGoon DC
    Cardiovasc Clin; 1980; 10(3):125-59. PubMed ID: 6991110
    [No Abstract]   [Full Text] [Related]  

  • 5. Silent valvular heart disease.
    Harvey WP
    Cardiovasc Clin; 1973; 5(2):77-95. PubMed ID: 4780194
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-invasive methods are reliable for quantification of valvular stenoses and regurgitation.
    Burckhardt D; Amann FW; Hoffmann A
    Z Kardiol; 1986; 75 Suppl 2():1-12. PubMed ID: 2941925
    [No Abstract]   [Full Text] [Related]  

  • 7. Valvular and hemodynamic assessment with CMR.
    Myerson SG
    Heart Fail Clin; 2009 Jul; 5(3):389-400, vi-vii. PubMed ID: 19564015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doppler echocardiography in the evaluation of valvular heart disease.
    Missri JC
    Can J Cardiol; 1986; 2(1):16-23. PubMed ID: 3633748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of chronic valvular disease.
    Stapleton JF
    Cardiovasc Clin; 1986; 16(2):105-47. PubMed ID: 3742519
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital valve disease.
    St John Sutton MG; St John Sutton MB
    Br J Hosp Med; 1979 Sep; 22(3):226-8, 233-51. PubMed ID: 519091
    [No Abstract]   [Full Text] [Related]  

  • 11. [Exercise testing in patients with valvular heart disease or with prosthetic valve replacement (author's transl)].
    Kraus F; Dacian S; Rudolph W
    Herz; 1982 Jun; 7(3):144-55. PubMed ID: 7095728
    [No Abstract]   [Full Text] [Related]  

  • 12. [Auscultation of the heart in pregnancy (author's transl)].
    Breuer HW
    MMW Munch Med Wochenschr; 1981 Nov; 123(45):1705-7. PubMed ID: 6795485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which patients with heart valve diseases require invasive evaluation?].
    Ugartemendia C; Esplugas E
    Rev Esp Cardiol; 1995 Apr; 48(4):215-22. PubMed ID: 7740141
    [No Abstract]   [Full Text] [Related]  

  • 14. NMR assessment of valvular disease.
    Herfkens RJ
    Radiol Med; 1990; 80(1-2):111-7. PubMed ID: 2217928
    [No Abstract]   [Full Text] [Related]  

  • 15. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease.
    Graham TP; Bricker JT; James FW; Strong WB
    Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S246-53. PubMed ID: 7934747
    [No Abstract]   [Full Text] [Related]  

  • 16. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension.
    Kaplan NM; Deveraux RB; Miller HS
    Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S268-70. PubMed ID: 7934750
    [No Abstract]   [Full Text] [Related]  

  • 17. [Auscultation and phonocardiography in acquired heart defects].
    Michel D
    Internist (Berl); 1965 Dec; 6(12):515-29. PubMed ID: 5334459
    [No Abstract]   [Full Text] [Related]  

  • 18. [Echocardiography. Part II--Valve dysfunctions].
    Matsumoto AY; Barbato AJ; Kaiser E; Lima EV; Savioli RM; Ortiz J; Del Nero E
    Arq Bras Cardiol; 1979 Sep; 33(3):217-23. PubMed ID: 543811
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and therapy of acquired heart valve defects in patients of advanced age].
    Schuster P; Trieb G; Sturm A
    Z Gerontol; 1985; 18(5):305-12. PubMed ID: 4072341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of laboratory diagnostic methods in the evaluation and followup of patients with valvular heart disease--relation to prognosis and outcome after valve replacement.
    Hirshfeld JW
    Cardiovasc Clin; 1986; 16(2):151-72. PubMed ID: 3742520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.